PCV7/13对携带肺炎链球菌血清型分布及菌毛流行的影响:14年重复横断面监测
在以色列中部8,473名<5.5岁儿童中开展2002–2016年12次重复横断面鼻咽携带监测,评估PCV7/PCV13接种对携带菌血清型及菌毛株流行的影响。PCV13血清型从接种前65.7%降至2016年3.3%,菌毛株从26.4%降至2014年1.7%后于两年后回升至12.8%。
要点
- PCV13血清型携带率从65.7%降至2016年3.3%。
- 菌毛株从26.4%降至2014年1.7%,两年后回升至12.8%。
- 菌毛在非疫苗血清型中重新出现,提示其定植优势。
核心结论
- PCV实施后疫苗血清型急剧下降,非疫苗血清型增加。
- 菌毛株几近消除后于PCV7/13实施7年后在多种非疫苗血清型中重新出现。
- 提示菌毛赋予定植优势。
研究设计与样本
- 2002–2016年在以色列中部<5.5岁就诊儿童中开展12次重复横断面鼻咽携带监测。
- 共纳入8,473名儿童,接种前7次、PCV7获批后实施前2次、接种后3次监测。
主要发现
- 肺炎链球菌携带率相对稳定(45.4%)。
- 接种前PCV13血清型占65.7%,菌毛存在于26.4%分离株。
- 接种前除19F菌毛株第一年后下降外,血清型分布及菌毛流行相对稳定。
- PCV7/13实施后VT13株至2016年几乎消除至3.3%。
- 菌毛株(主要为VT13血清型)至2014年几乎消除至1.7%,两年后非VT株中菌毛回升至全部肺炎球菌的12.8%。
临床怎么用
- 监测儿童肺炎链球菌携带型别及菌毛流行变化,评估PCV长期效果。
- 关注非疫苗血清型中菌毛重现对定植与传播的潜在影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: S. pneumoniae carriage by children is a major source of pneumococcal transmission, and the initial step prior to infection. Pilus type 1, reported in ~30% of pneumococcal strains in the pre-vaccine era, contributes to pneumococcal colonization and virulence. In this study, we report the impact of the pneumococcal conjugate vaccine (PCV), PCV7/PCV13 sequential implementation on serotype distribution, and on the prevalence of piliated strains among carried pneumococci during the pre- and post-vaccine eras. METHODS: During 2002-2016, 12 repeated cross-sectional surveillances of nasopharyngeal S. pneumoniae carriage were conducted among 8,473 children <5.5 years old visiting primary care physicians in Central Israel. Seven biannual surveillances in the pre-PCV period, 2 surveillances after PCV7 was licensed but before implementation in the National Immunization Plan, and 3 additional surveillances in the post-PCV period. S. pneumoniae serotype distribution and prevalence of piliated strains were assessed. RESULTS: Carriage of S. pneumoniae was relatively stable (45.4%). The prevalence of serotypes included in PCV13 was 65.7%, in the pre-vaccine period and the pilus was present in 26.4% of isolates. The distribution of serotypes and the pilus prevalence in the pre-PCV period was relatively stable except for a decrease in prevalence of piliated 19F, observed following the first study year. Following PCV7/PCV13 implementation, vaccine type 13 (VT13) strains were nearly eliminated to 3.3% by 2016. Piliated strains, which were primarily of VT13 serotypes, initially followed a similar trend and were nearly eliminated by 2014 (1.7%). Yet, two years later, pilus prevalence re-emerged among non-VT strains to 12.8% of all pneumococci. CONCLUSIONS: Following PCV implementation, a dramatic and rapid decrease in VT strains prevalence was observed with a concomitant increase in non-VT strains. Piliated strains were nearly eliminated, yet re-emerged 7 years following PCV7/PCV13 implementation in various non-VT strains. This suggests that the pilus confers an advantage in colonization.
引用
- Kasher M, Roizin H, Cohen A, et al. The impact of PCV7/13 on the distribution of carried pneumococcal serotypes and on pilus prevalence; 14 years of repeated cross-sectional surveillance. Vaccine. 2020. PMID: 32224005. doi:10.1016/j.vaccine.2020.03.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。